In a recently published study, researchers examined the expression of MYB in prostate tumor tissues of various histological grades and clinical stages from Black and white patients, and evaluated if it could be used to predict the risk of cancer recurrence following primary therapy.
As interim chair, Christopher Keel, D.O., FACS, led the creation of a five-year urology residency program. He also has worked to recruit urology specialists with an interest in academic medicine.
“This goes to show that our team is engaged with our regional academic community to provide subspecialized care to the people of the Gulf Coast,” said USA Health urologist Christopher Keel, D.O., interim chair of urology.
“To address race-associated prostate cancer disparities, it is important first to understand how tumors from different races differ in their biology and molecular landscape,” said Ajay Singh, Ph.D.
The Office of Graduate Medical Education recently received approval from the Accreditation Council for Graduate Medical Education (ACGME) for the five-year residency program to begin in July.
The robot-assisted surgical system allows for a single point of entry with the potential for less pain and shorter hospital stays for prostatectomy patients at USA Health.
“Our preliminary studies make strong suggestions for a pathobiological involvement of nicotine exposure in prostate cancer aggressiveness and therapy resistance.”
Christopher Keel, D.O., a urologist with University Urology and adjunct assistant professor of surgery at the University of South Alabama College of Medicine, presented at the October Med School Café.
The October Med School Café will feature Christopher Keel, D.O., a urologist with University Urology and adjunct assistant professor of surgery at the University of South Alabama College of Medicine.
